SE415762B - Forfarande for framstellnig av terapeutiskt verksamma hexahysrodibenso(b,d)-pyraner med hydroxi-och/eller alkanoyloxi-substituenter i 1-och 9-stellningarna - Google Patents

Forfarande for framstellnig av terapeutiskt verksamma hexahysrodibenso(b,d)-pyraner med hydroxi-och/eller alkanoyloxi-substituenter i 1-och 9-stellningarna

Info

Publication number
SE415762B
SE415762B SE7413833A SE7413833A SE415762B SE 415762 B SE415762 B SE 415762B SE 7413833 A SE7413833 A SE 7413833A SE 7413833 A SE7413833 A SE 7413833A SE 415762 B SE415762 B SE 415762B
Authority
SE
Sweden
Prior art keywords
substitutors
hexahysrodibenso
pyranes
alkanoyloxy
hydroxy
Prior art date
Application number
SE7413833A
Other languages
English (en)
Swedish (sv)
Other versions
SE7413833L (ro
Inventor
R A Archer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7413833L publication Critical patent/SE7413833L/xx
Publication of SE415762B publication Critical patent/SE415762B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
SE7413833A 1973-11-05 1974-11-04 Forfarande for framstellnig av terapeutiskt verksamma hexahysrodibenso(b,d)-pyraner med hydroxi-och/eller alkanoyloxi-substituenter i 1-och 9-stellningarna SE415762B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/413,010 US3968125A (en) 1973-11-05 1973-11-05 Dihydroxyhexahydrodibenzo[b,d]pyrans

Publications (2)

Publication Number Publication Date
SE7413833L SE7413833L (ro) 1975-05-06
SE415762B true SE415762B (sv) 1980-10-27

Family

ID=23635420

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7413833A SE415762B (sv) 1973-11-05 1974-11-04 Forfarande for framstellnig av terapeutiskt verksamma hexahysrodibenso(b,d)-pyraner med hydroxi-och/eller alkanoyloxi-substituenter i 1-och 9-stellningarna

Country Status (26)

Country Link
US (1) US3968125A (ro)
JP (1) JPS6033835B2 (ro)
AR (1) AR202318A1 (ro)
AT (1) AT336012B (ro)
BE (1) BE821716A (ro)
BG (1) BG26387A3 (ro)
CA (1) CA1023753A (ro)
CH (1) CH605894A5 (ro)
CS (1) CS193507B2 (ro)
DD (1) DD116230A5 (ro)
DE (1) DE2451934C2 (ro)
DK (1) DK136719B (ro)
ES (1) ES431674A1 (ro)
FR (1) FR2249664B1 (ro)
GB (1) GB1487637A (ro)
HU (1) HU169193B (ro)
IE (1) IE40023B1 (ro)
IL (1) IL45644A (ro)
NL (1) NL7414439A (ro)
PH (1) PH11788A (ro)
PL (2) PL93908B1 (ro)
RO (1) RO71766A (ro)
SE (1) SE415762B (ro)
SU (1) SU524517A3 (ro)
YU (1) YU36515B (ro)
ZA (1) ZA745751B (ro)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
JPS6299930U (ro) * 1985-12-12 1987-06-25
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
WO2003070277A1 (en) * 2002-02-19 2003-08-28 Shionogi & Co., Ltd. Antipruritics
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
US8829043B2 (en) 2008-02-08 2014-09-09 Nektar Therapeutics Oligome-cannabinoid conjugates
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN110996926A (zh) 2017-07-20 2020-04-10 耶路撒冷希伯来大学伊萨姆研究开发有限公司 用于将亲脂性化合物递送进入和/或穿过皮肤的药物膜组合物
CN111278425B (zh) 2017-09-11 2024-06-11 耶路撒冷希伯来大学伊萨姆研究开发有限公司 用于向脑部经鼻给药药物和用于全身作用的组合物和方法
US20200345656A1 (en) 2017-11-29 2020-11-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cannabinoids compositions and methods
EP3873436A1 (en) 2018-11-04 2021-09-08 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Orally administrable cannabinoids-containing compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
CH558792A (de) * 1971-10-14 1975-02-14 Petrzilka Theodor Verfahren zur herstellung von tetrahydrodibenzopyranen.

Also Published As

Publication number Publication date
GB1487637A (en) 1977-10-05
FR2249664A1 (ro) 1975-05-30
BE821716A (fr) 1975-04-30
SE7413833L (ro) 1975-05-06
JPS6033835B2 (ja) 1985-08-05
BG26387A3 (bg) 1979-03-15
DE2451934A1 (de) 1975-05-07
NL7414439A (nl) 1975-05-07
PL95748B1 (pl) 1977-11-30
AU7321274A (en) 1976-03-18
DK573274A (ro) 1975-07-07
IL45644A (en) 1978-03-10
CA1023753A (en) 1978-01-03
AR202318A1 (es) 1975-05-30
DE2451934C2 (de) 1983-10-06
AT336012B (de) 1977-04-12
YU36515B (en) 1984-02-29
HU169193B (ro) 1976-10-28
DK136719C (ro) 1978-04-24
RO71766A (ro) 1982-12-06
IL45644A0 (en) 1974-11-29
ZA745751B (en) 1976-04-28
YU265874A (en) 1982-02-25
ATA886374A (de) 1976-08-15
PH11788A (en) 1978-07-05
IE40023L (en) 1975-05-05
SU524517A3 (ru) 1976-08-05
US3968125A (en) 1976-07-06
CS193507B2 (en) 1979-10-31
JPS5071678A (ro) 1975-06-13
DK136719B (da) 1977-11-14
PL93908B1 (ro) 1977-07-30
IE40023B1 (en) 1979-02-28
ES431674A1 (es) 1976-11-16
CH605894A5 (ro) 1978-10-13
FR2249664B1 (ro) 1978-03-24
DD116230A5 (ro) 1975-11-12

Similar Documents

Publication Publication Date Title
KE2755A (en) New phenoxy-alkyl-carboxylic acid derivatives and the preparation thereof
AU462479B2 (en) Improvements in or relating tothe manufacture of tiles
CA975595A (en) Guard-rail structure
CA986938A (en) Phenylpyridazines and the preparation thereof
SE409459B (sv) Forfarande for framstellning av 6'-deoxi-6'-substituerat eller-osubstituerat amino-lividomycin
AU474263B2 (en) Piperidine-spiro-hydantoin derivatives and their use as stabilizers
ZA724891B (en) New n(6)-substituted adenosine derivatives and the preparation thereof
ZA726638B (en) New phenoxy-alkyl-carboxylic acid derivatives and the preparation thereof
TR18049A (tr) Triasetonamin'in imaline mahsus usul
AU4575572A (en) Improvements in building structures
AU458790B2 (en) Adenosine 5' carnoxylate derivatives
CA968239A (en) Carpet and preparation thereof
GB1403550A (en) 3-carbamoyl-3-hyeroxy-4-halobutyric acid and the preparation thereof
IL40197A0 (en) New derivatives of 17-hydroxy-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid and the corresponding gamma-lactones and their preparation
AU475591B2 (en) Improvements in or relating to shower assemblies
CA918825A (en) Web fasteners
ZA728091B (en) New heterocyclic-substituted nebularin derivatives and the preparation thereof
EG10793A (en) Indole-carboxylic acid derivatives and the preparation thereof
AU456984B2 (en) Improvements in or relating toscan-conversion arrangements
ZA76642B (en) 7 - (alpha, alpha - disubstituted - acetamido) - 3 - substituted-3-cephem-4-carboxylic acids and the preparation thereof
AU458664B2 (en) Improvements in or relating to building assemblies
AU455557B2 (en) Web fasteners
AU454894B2 (en) Turbomachine structure
AU428329B2 (en) 3-METHOXY 17a-METHYL 20-OXO 19-NOR PREGNA-1,3,5[10]-TRIENE AND ITS PREPARATION
ZA726558B (en) New n(6)-disubstituted adenosine derivatives and the preparation thereof